Livia Cristina Buriche Ferreira da Silva

Livia Cristina Buriche Ferreira da Silva

Auto-generated profile, based on publicly available information

Livia Cristina Buriche Ferreira da Silva

Universidade Federal do Rio de Janeiro

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2024 in Revista Brasileira de Qualidade de Vida
Verified
Journal Article
Open access
PDF file
LSLivia Cristina Buriche Ferreira da Silva
Livia Cristina Buriche Ferreira da Silva
NSNicole Serqueira da Silva
Nicole Serqueira da Silva
JCJuliana Lima de Oliveira Amorim Cabral
Juliana Lima de Oliveira Amorim Cabral
JEJônatas Caldeira Esteves
Jônatas Caldeira Esteves
ITInger Teixeira Campos Tuñas
Inger Teixeira Campos Tuñas
OBJETIVO: Identificar as principais propriedades dos fios de polidioxanona (PDO) disponíveis, suas indicações, limitações e complicações relatadas na literatura.MÉTODOS: Para a revisão de literatura narrativa, foram utilizadas as bases de dados PubMed e Biblioteca Virtual em Saúde (BVS). Foram selecionados artigos publicados em inglês, no período de 2017 a 2022, utilizando-se os termos Polydioxanone e Thread como chaves de busca. Após a aplicação dos critérios de inclusão e exclusão, 25 artigos foram selecionados para o estudo.RESULTADOS: Constatou-se que o lifting facial com fios absorvíveis de PDO é um procedimento minimamente invasivo, caracterizado por baixas taxas de complicações. Dentre as propriedades vantajosas dos fios de PDO, destacam-se sua biodegradabilidade e biocompatibilidade, além de um processo de degradação relativamente lento. Outras características positivas observadas incluem o curto tempo cirúrgico, o efeito temporário do procedimento e a possibilidade de realização sob anestesia local.CONCLUSÕES: O fio de PDO, biocompatível e estimulante de colágeno, oferece boa resistência à tração, sendo promissor para harmonização orofacial. Indicado para pacientes com ptose leve a moderada ou paralisia facial que buscam simetria, não é adequado para aqueles que esperam resultados permanentes ou têm expectativas irrealistas. Complicações possíveis incluem edema, hematomas, equimoses, ondulações e assimetrias, que, embora não graves, devem ser informadas antes do procedimento.

23 March 2023 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
NSNicole Serqueira da Silva
Nicole Serqueira da Silva
SSSusana Braga Santoro Santiago
Susana Braga Santoro Santiago
DCDaniel Neto Campos
Daniel Neto Campos
LSLivia Cristina Buriche Ferreira da Silva
Livia Cristina Buriche Ferreira da Silva
JCJuliana Lima de Oliveira Amorim Cabral
Juliana Lima de Oliveira Amorim Cabral
ITInger Teixeira de Campos Tuñas
Inger Teixeira de Campos Tuñas
Objective: The purpose of this paper is to discuss the surgical methods available for the treatment of MRONJ, pointing out their advantages and limitations. Methodology: An integrative review of the literature was performed by searching the PubMed virtual database using the MeSH term "bisphosphonate associated osteonecrosis of the jaw/surgery" and including 26 publications. Results: Surgical intervention is presented as a treatment option in an attempt to reduce disease progression with the recognition that this early intervention may predict beneficial outcomes for the patient. Surgical approaches confer superior treatment outcomes over conservative treatments, with success rates of 80-90% and 10-62%, respectively. To establish treatment, consideration should be given to therapy for removing nonhealing exposed bone, which can be accomplished through curettage, sequestrectomy, and surgical resection. When approaching soft tissue, different flaps can be performed, according to their indications. Conclusion: Surgical treatment has shown maintenance of mucosal coverage, improved quality of life, and quick resumption of antiresorptive therapy for all stages of the disease, with high rates of therapeutic success. However, continued efforts should be encouraged to investigate the best treatment for this pathology.

23 March 2023 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
JCJuliana Lima de Oliveira Amorim Cabral
Juliana Lima de Oliveira Amorim Cabral
SSSusana Braga Santoro Santiago
Susana Braga Santoro Santiago
NSNicole Serqueira da Silva
Nicole Serqueira da Silva
LSLivia Cristina Buriche Ferreira da Silva
Livia Cristina Buriche Ferreira da Silva
CSCarina Maciel Silva-Boghossian
Carina Maciel Silva-Boghossian
ITInger Teixeira de Campos Tuñas
Inger Teixeira de Campos Tuñas
Introduction: Medication-related Osteonecrosis of the Jaw (MRONJ) is a condition that may affect patients undergoing oral surgery procedures that use antiresorptive drugs. It is essential that the Doctor of Dental Surgery (DDS) is familiar with the pathology and how to diagnose, prevent and approach it. Objectives: To perform a literature review on MRONJ and to guide the DDS on how to manage the affected patients. Methodology: a systematized search was conducted on the PubMed virtual database using the terms: "diphosphonates", "dentist's practice pattern", "dentists", "dentist's role" and "Bisphosphonate-Associated Osteonecrosis of the Jaw". 29 articles in English, published in the last 5 years, were included. Results and discussion: MRONJ is characterized by exposed and necrotic bone that persists for more than 8 weeks and happens in patients taking antiresorptive agents. It is multifactorial and its severity depends on the dosage, route of administration, and treatment duration. Its management must be multidisciplinary to improve the patient's quality of life. The DDS must focus on prevention. Every patient should have their oral health evaluated before starting antiresorptive therapy and be informed of its risks and benefits. Most DDSs do not feel confident to adequately manage these cases, even though information on MRONJ is more widespread among younger DDSs and recent graduates. Conclusion: MRONJ is a harmful condition for the patient and it is the DDS's responsibility to know how to treat and prevent it, by having adequate knowledge of this pathology and making decisions based on the latest scientific evidence.